Tags:BodyCauseClinicDeviceEquipmentFertilityITManufacturingMedicalMedTechRecruitingTechnology
AblaCare aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. AblaCare's procedure is done transvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.
Location: France, Ile-de-France, Paris
Member count: 1-10
Total raised: $11.258395M
Founded date: 2017

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
10.07.2019Series A$11.258395...-finsmes.co...

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
10.07.2019Daily fund...Perq raised $6 M; Jacobi close...-Kristin Ka...vator.tv/n...
10.07.2019AblaCare R...AblaCare, a Paris, France-base...France-finsmes.co...
09.07.2019Fierce 15 ...FierceMedTech Fierce 15 winner...MedTech-fiercebiot...
09.07.2019Fierce 15 ...FierceMedTech Fierce 15 winner...MedTech-fiercebiot...
03.10.2018Here’s who...The selection process whittled...--medcitynew...
-Here’s who...Since 2012, nonprofit startup ...--medcitynew...